Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2415

Gilead deepens its stake in Assembly Biosciences; NGM licenses out MASH drug

$
0
0
Plus, news about Abilita Therapeutics, Orion, Novartis, XGEN Venture, Palleon, Henlius, TigaTx, HERVolution Therapeutics and Krystal Biotech: Gilead now owns 30% of Assembly Biosciences: The drugmaker made a $20.1 million equity ...

Viewing all articles
Browse latest Browse all 2415

Trending Articles